<img alt="" src="https://secure.wake4tidy.com/244317.png" style="display:none;">
2017-11-06

Free webinar April 6: Automated purity and integrity analysis of gene therapy vectors

Time: 3:00pm London, 10:00am New York

2017-11-06

Record turnover for NOW Electronics in its first year as a Vironova-owned company

2016 saw Mikael Wik appointed as new CEO and a record sales performance that beat all previous years, with a turnover of 25,9 MSEK. The two founders and previous leaders since 1985 continue to be active in sales and business development.

2017-11-06

European MiniTEM seminar; “Automated virus particle characterization”, March 30 in Leiden

Everybody with a need to speed up process development or secure final product quality of virus particle based therapeutics should attend this seminar. The event offers an opportunity to learn about Vironova’s solutions for nanoparticle...

2017-11-06

Vironova AB is a partner in a Big Data and Computational Science project that has received 29 M SEK in funding from the Swedish foundation for Strategic Research.

Vironova AB is once again a participant in a cutting-edge research program, this time in a Big Data and Computational Science entitled program “Hierarchical Analysis of Temporal and Spatial Image Data.” Transmission electron microscopy (TEM) images...

2017-11-06

Vironova AB signs one-year agreement with the U.S. Food and Drug Administration to beta test proprietary Vironova Analyzing Software (VAS).

In one of the fastest growing drug development areas today, nano-particles (for example liposomes), visible using electron microscopy, are used to deliver drugs to their exact targets in the body.

2017-11-06

Vironova is together with AstraZeneca part of a drug delivery technology Industrial Research Centre which has received 75M SEK from the Swedish foundation for Strategic Research (SSF).

At Vironova we are proud about being part of this new FoRmulaEx centre that has been recognized by SSF to meet the highest international scientific standards. The FoRmulaEx centre will develop methods for efficient and robust delivery of complex,...

2017-11-06

Article published in Bioprocess International

Ask the Expert article "Reveal Information That Provides Insights” in the December issue of BioProcess International. The article features Josefina Nilsson and Gustaf Kylberg who present the benefits of using MiniTEM in purity analysis during...

2017-11-06

Notice of extra general meeting

Shareholders of Vironova AB (publ), are hereby invited to the extra general meeting on Wednesday, December 21, 2016 at. 15:00 at company headquarters, Gävlegatan 22, exit C, 113 30 Stockholm, Sweden

2017-11-06

Interview in DI Digital with tech-investor Eva Redhe, shareholder in Vironova.

Eva is recognized by DI Digital as one of Sweden’s most powerful tech-investors. She has a long career in the financial sector. After 30 years in the industry, as an entrepreneur and an employee at Investor, she completed her operative career as CEO...

2017-11-06

His Majesty Carl XVI Gustaf prize for remarkable entrepreneurial achievements to Mohammed Homman, founder and CEO of Vironova

Mohammed receives the prize as a recognition for his open minded, energetic and solution oriented approach that has resulted in positioning Vironova as a highly versatile and multicultural working place and a company that attracts top talents that...